Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19

The development of biological disease-modifying antirheumatic drugs (bDMARDs) and target synthetic DMARDs (tsDMARDs), also known as small molecule inhibitors, represent a breakthrough in rheumatoid arthritis (RA) treatment. The tsDMARDs are a large family of small molecules targeting mostly the seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Massalska, Magdalena, Maslinski, Wlodzimierz, Ciechomska, Marzena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464410/
https://www.ncbi.nlm.nih.gov/pubmed/32796683
http://dx.doi.org/10.3390/cells9081876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464410/
https://www.ncbi.nlm.nih.gov/pubmed/32796683
http://dx.doi.org/10.3390/cells9081876

Ejemplares similares